* Myelodysplasia (MDS) IPPS Int-2 or high risk, or refractory anemia with severe pancytopenia or high risk cytogenetics
* Chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), marginal zone B-cell lymphoma or follicular lymphoma that have progressed after two prior therapies
* Lymphoplasmacytic, lymphoma, mantle-cell lymphoma, prolymphocytic leukemia after initial therapy and complete or partial remission
You may not be if
* Multiple myeloma beyond 2nd partial remission
Preparative regimen consisting of cyclophosphamide, fludarabine, and total body irradiation
Adequate organ function
Symptomatic underlying pulmonary disease or requiring oxygen
Active infection
HIV positive
Pregnant or nursing
Clareo Health | Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
